^Frydenberg, A; Starr, M. Hand, foot and mouth disease.. Australian family physician. August 2003, 32 (8): 594–5. PMID 12973865.
^Ooi, MH; Wong, SC; Lewthwaite, P; Cardosa, MJ; Solomon, T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurology. 2010, 9 (11): 1097–1105. PMID 20965438. doi:10.1016/S1474-4422(10)70209-X.
^ 4.04.14.2Kaminska, K; Martinetti, G; Lucchini, R; Kaya, G; Mainetti, C. Coxsackievirus A6 and Hand, Foot, and Mouth Disease: Three Case Reports of Familial Child-to-Immunocompetent Adult Transmission and a Literature Review. Case Reports in Dermatology. 2013, 5 (2): 203–209. PMID 24019771. doi:10.1159/000354533.
^Hoy, NY; Leung, AK; Metelitsa, AI; Adams, S. New concepts in median nail dystrophy, onychomycosis, and hand, foot and mouth disease nail pathology. ISRN Dermatology. 2012, 2012 (680163): 680163. PMID 22462009. doi:10.5402/2012/680163.
^ 6.06.1Longo, Dan L. Harrison's principles of internal medicine. 18th. New York: McGraw-Hill. 2012. ISBN 978-0-07174889-6.
^Li, Y; Zhu, R; Qian, Y; Deng, J. The characteristics of blood glucose and WBC counts in peripheral blood of cases of hand foot and mouth disease in China: a systematic review. PLOS ONE. 2012, 7 (1): e29003. PMID 22235257. doi:10.1371/journal.pone.0029003.
^Diagnosis. CDC. August 18, 2015 [15 May 2016]. (原始内容存档于2016-05-14).
^Pourianfar HR, Grollo L. Development of antiviral agents toward enterovirus 71 infection. J Microbiol Immunol Infect. February 2014,. S1684-1182 (13): 00236–3. PMID 24560700. doi:10.1016/j.jmii.2013.11.011.